Endologix Profit Margin 2006-2019 | ELGX

Current and historical gross margin, operating margin and net profit margin for Endologix (ELGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Endologix net profit margin as of June 30, 2019 is -60.32%.
Endologix Annual Profit Margins
Endologix Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.069B $0.156B
Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment of atherosclerosis.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.211B 22.69
McKesson (MCK) United States $26.941B 10.41
AmerisourceBergen (ABC) United States $17.787B 12.23
Laboratory Of America Holdings (LH) United States $16.717B 15.83
Cooper (COO) United States $14.934B 25.27
Align Technology (ALGN) United States $14.406B 39.29
Cardinal Health (CAH) United States $14.316B 9.09
Straumann Holding AG (SAUHF) Switzerland $13.094B 0.00
DENTSPLY SIRONA (XRAY) United States $11.187B 23.65
West Pharmaceutical Services (WST) United States $10.570B 45.94
Henry Schein (HSIC) United States $9.363B 16.66
CONMED (CNMD) United States $2.865B 43.65
Patterson (PDCO) United States $1.671B 12.40
Merit Medical Systems (MMSI) United States $1.654B 17.23
Atrion (ATRI) United States $1.471B 40.92
STAAR Surgical (STAA) United States $1.328B 78.45
Antares Pharma (ATRS) United States $0.590B 0.00
Invacare (IVC) United States $0.248B 0.00
Lifevantage (LFVN) United States $0.192B 23.10
Pro-Dex (PDEX) United States $0.061B 19.48
Milestone Scientific (MLSS) United States $0.040B 0.00
Retractable Technologies (RVP) United States $0.030B 0.00
Biolase (BIOL) United States $0.022B 0.00